Anti-tumour therapeutic efficacy of OX40L in murine tumour model

This publication has 33 references indexed in Scilit:

• The B7 Family of Ligands and Its Receptors: New Pathways for Costimulation and Inhibition of Immune Responses
  Annual Review of Immunology, 2002
• Disabled Infectious Single-Cycle Herpes Simplex Virus as an Oncolytic Vector for Immunotherapy of Colorectal Cancer
  Human Gene Therapy, 1999
• Antibodies to OX-40 (CD134) can identify and eliminate autoreactive T cells: implications for human autoimmune disease
  Molecular Medicine Today, 1998
• The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells.
  The Journal of Experimental Medicine, 1996
• The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response.
  The Journal of Experimental Medicine, 1996
• Selective depletion of myelin–reactive T cells with the anti–OX–40 antibody ameliorates autoimmune encephalomyelitis
  Nature Medicine, 1996
• Costimulation of T-cell-mediated tumor immunity
  Cancer Chemotherapy and Pharmacology, 1996
• Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells
  Immunity, 1995
• The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death
  Cell, 1994
• The two-signal model of lymphocyte activation twenty-one years later
  Immunology Today, 1992